CARISMA THERAPEUTICS INC
CARM
Health Care
1
exclusion reason
1 theme
CARISMA THERAPEUTICS INC is screened out under 1 exclusion reason spanning 1 issue category.
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. It is a statement of values.
Carisma Therapeutics is a clinical-stage biotechnology company pioneering macrophage engineering to develop therapies for fibrosis and cancer. Its core research and development model relies on preclinical animal testing to evaluate the safety and efficacy of its investigational cell therapies. The company's primary business activity is developing these novel treatments, a process that inherently involves the commercial exploitation of animals in laboratory research.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.